Updated:
The Sontag Foundation
The Sontag Foundation is dedicated to advancing brain cancer research by investing in scientists committed to bold, innovative, and transformative ideas.
Overview
The Sontag Foundation is dedicated to advancing brain cancer research by investing in scientists committed to bold, innovative, and transformative ideas. Funding of research related to brain tumors is its main mission. It has grown into one of the largest private funders of brain tumor research in North America. It also supports patients through related initiatives including the Brain Tumor Network.
General information
Firm type
Private Equity
Year founded
2002
Location
Region
North America
Country
United States
City
Ponte Vedra Beach
Corporate office
Ponte Vedra Beach, FL, United States
Principals
Rick Sontag
Founder and President
Sector focus
Frequently asked questions
What is the relationship between the Foundation's grantmaking and its investment activities?
The Sontag Foundation runs a unified life sciences strategy with two arms: a philanthropic grant program funding brain cancer research and a private investment vehicle backing early-stage healthcare companies. Both arms draw on the same domain expertise and networks, but the investment side seeks market-rate returns while grants target scientific advancement without a commercial return requirement.
Who makes investment decisions at The Sontag Foundation?
Rick Sontag, the founder and president, oversees all investment decisions. He brings direct operating experience from co-founding and selling medical device company SciMed Life Systems, and his network within the life sciences community informs both the grantmaking and for-profit investment pipelines.
What investment stages does the Foundation target in its for-profit portfolio?
The investment arm targets early-stage healthcare ventures, including seed-stage and startup rounds. The focus is on life sciences and medical technology companies where the Foundation's internal scientific expertise can inform diligence — often companies translating academic research into clinical applications.
How transparent is The Sontag Foundation about its portfolio companies?
The Foundation is selective about disclosure. Its philanthropic grants are a matter of public record through IRS Form 990 filings and press releases, but specific investments in the for-profit portfolio are not broadly promoted. Occasional portfolio names surface through funding-round announcements or regulatory filings.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: